A Study in Schizophrenia Patients

NCT01086748 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

880

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Risperidone
DRUG: Placebo
DRUG: LY2140023

Sponsor

Eli Lilly and Company